OpenDNA Press Releases

• Published on June 3, 2025 - 13:36 GMT

  New Collaboration Between Psifas and OpenDNA: Predicting Common Diseases Through AI and Genomic Data

  HAIFA, ISRAEL, ISRAEL, June 3, 2025 /⁨EINPresswire.com⁩/ -- The Israeli National Initiative for Personalized Medicine, Psifas, and OpenDNA a Genomic AI biotech company have announced a strategic collaboration to develop artificial intelligence models that …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on May 19, 2025 - 13:00 GMT

  OpenDNA Secures Exclusive License to Polygenic Technology for Personalized Diabetes Treatment from Cleveland Clinic

  OpenDNA Secures Exclusive License Agreement to Commercialize Advanced Polygenic Technology for Personalized Diabetes Treatment Developed at Cleveland Clinic CLEVELAND, OH, UNITED STATES, May 19, 2025 /⁨EINPresswire.com⁩/ -- OpenDNA and Cleveland Clinic …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on April 14, 2025 - 14:52 GMT

  Blossom Family Medicine Partners with OpenDNA to Bring Precision Genetic Testing to Primary Care

  ARLINGTON HEIGHTS, IL, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Blossom Family Medicine is proud to announce a strategic collaboration with OpenDNA, a leader in precision medicine and AI-powered genetic analysis. This partnership brings …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on March 31, 2025 - 13:00 GMT

  OpenDNA and Mayo Clinic Present AI-Powered Heart Disease Risk Prediction Model at the American College of Cardiology

  OpenDNA and Mayo Clinic Presents AI-Powered Heart Disease Risk Prediction Model at the American College of Cardiology Conference 2025 in Chicago GAITHERSBURG, MD, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- This week, OpenDNA and Mayo Clinic …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on March 17, 2025 - 15:03 GMT

  Encore Concierge Medicine and OpenDNA Announce Strategic Partnership to Offer Advanced AI-Driven Genetic Screening Tests

  Encore Concierge Medicine and OpenDNA Announce Strategic Partnership to Offer Advanced AI-Driven Genetic and Clinical Screening Tests CHICAGO AND GAITHERSBURG, MD, UNITED STATES, March 17, 2025 /⁨EINPresswire.com⁩/ -- Encore Concierge Medicine, a leader …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
• Published on February 17, 2025 - 14:00 GMT

  Harper Health Partners with OpenDNA to Provide AI-Based Genetic Risk Testing

  Harper Health Partners with OpenDNA to Provide Patients with AI-Based Genetic Risk Testing for Cardiometabolic Diseases and Cancer GAITHERSBURG, MD, UNITED STATES, February 17, 2025 /⁨EINPresswire.com⁩/ -- Harper Health, a leading primary care provider …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on January 29, 2025 - 14:00 GMT

  OpenDNA Launches TotalRisk+, a Revolutionary AI based Genetic Test for Cancer Screening

  GAITHERSBURG, MD, UNITED STATES, January 29, 2025 /⁨EINPresswire.com⁩/ -- OpenDNA, a leading innovator in personalized genetic health, today announced the launch of TotalRisk+, a groundbreaking genetic test designed to assess an individual’s risk for …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 2, 2024 - 13:00 GMT

  OpenDNA Expands CardioRisk+ Genetic Testing Panel to Include Obesity Risk

  GAITHERSBURG, MD, UNITED STATES, December 2, 2024 /⁨EINPresswire.com⁩/ -- OpenDNA, a leading provider of advanced genetic testing solutions, today announced the launch of a new genetic test for obesity, which will be added to its comprehensive CardioRisk+ …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on November 16, 2023 - 15:15 GMT

  OpenDNA Partners with PartnerMD to Provide Patients with AI-Based Genetic Risk Testing for Cardiometabolic diseases

  GAITHERSBURG, MARYLAND, UNITED STATES, November 16, 2023 /⁨EINPresswire.com⁩/ -- OpenDNA, a leading provider of precision medicine AI solutions focused on genetic testing and risk assessment for cardiometabolic and cancer, and PartnerMD, a leader in …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on June 8, 2023 - 13:00 GMT

  

  OpenDNA Announces Successful Conclusion of 150 Patient Clinical Study

  GAITHERSBURG, MD, UNITED STATES, June 8, 2023 /⁨EINPresswire.com⁩/ -- Study Demonstrates the Utilization, Impact, and Precision of OpenDNA's AI-Powered Platform for Predicting Cardiovascular Disease Risk OpenDNA, a leading provider of precision …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...